95% CI for β | ||||
Stand.β | Lower | Upper | P values | |
US GS | 0.59 | 0.28 | 0.89 | <0.001 |
66SJC | 0.26 | 0.10 | 0.42 | <0.00 |
ESR | 0.25 | 0.06 | 0.43 | 0.009 |
DAS28ESR | 0.20 | 0.05 | 0.35 | <0.001 |
EGA | 0.19 | 0.04 | 0.35 | 0.017 |
CRP | 0.16 | 0.02 | 0.30 | 0.03 |
68TJC | −0.08 | −0.23 | 0.08 | 0.332 |
PAIN | 0.03 | −0.10 | 0.16 | 0.693 |
PGA | 0.06 | −0.08 | 0.20 | 0.418 |
RAID | 0.03 | −0.13 | 0.18 | 0.742 |
MHAQ | 0.18 | −0.02 | 0.38 | 0.080 |
DAPSA | 0.003 | −0.16 | 0.16 | 0.971 |
HADS.A | −0.14 | −0.33 | 0.05 | 0.137 |
HADS.D | −0.07 | −0.21 | 0.08 | 0.379 |
BASDAI | 0.08 | −0.09 | 0.18 | 0.359 |
Statistically significant results are presented in bold.
*Generalised estimating equations models are adjusted for age, gender and disease duration.
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C-reactive protein; DAPSA, Disease Activity index for PSoriatic Arthritis; DAS28ESR, Disease Activity Score for 28 joints with ESR; EGA, examinator's global assessment; ESR, erythrocyte sedimentation rate; HADS.A, The Hospital Anxiety Depression Scale—anxiety; HADS.D, The Hospital Anxiety Depression Scale—depression; MHAQ, Modified Health Assessment Questionnaire; PGA, patient's global assessment; RAID, Rheumatoid Arthritis Impact of Disease; 66SJC, 66 swollen joint count; 68TJC, 68 tender joint count; US GS, Ultrasound Grey Scale; US PD, ultrasound power Doppler.